Titan shines on better recovery rates
Shares of Titan Company jumped close to 6% to Rs 1,268 on the BSE on Wednesday after the company said its jewellery business did very well in the September quarter (Q2FY21), with a recovery rate of around 98 per cent (excluding sale of raw gold), compared to the revenue of the corresponding quarter in the last year.
Titan’s jewellery division saw a recovery rate of around 98% (excluding the sale of raw gold) in the September quarter compared to the revenue of the same period last year. The walk-ins have been improving with conversion rates and average ticket size being higher compared to the same period of last year. Although, it’s worth noting here that the September 2019 quarter represents a comparatively low base wherein jewellery revenues had declined by 1.5% on a year-on-year basis.
The Company is now gearing up to gain well from the upcoming festival season which is expected to further uplift the mood of the consumers. The festival season will commence about 15 days later in the current year. The Company continued to sell excess gold in its inventory and the quarter had a sale of Rs 390 crore of raw gold. This has helped improve the cash flow of the division significantly.
Titan enjoys a dominant position in the leading lifestyle categories of organized jewelry and watches. Its medium-term growth outlook remains good, supported by various initiatives to drive higher sales of wedding/studded/fashion jewelry, a strengthening value proposition, and new customer acquisitions.
Titan also stands to benefit from higher market share as jewelry purchases shift to organized players and the unorganized segment becomes less competitive. However the company is not immune to the risks from COVID-19 impact which will be a drag on F21 operating metrics.
This document is meant for the recipient only for use as intended and not for circulation. This document should not be reproduced or copied or made available to others. The information contained herein is from the public domain or sources believed to be reliable. While reasonable care has been taken to ensure that information given is at the time believed to be fair and correct and opinions based thereupon are reasonable, due to the very nature of research it cannot be warranted or represented that it is accurate or complete and it should not be relied upon as such. Also above note is not a recommendation to Buy or SELL and is only a view based on facts and figures and we will be in no way responsible for any losses incurred by anyone who uses this information to either trade or invests securities mentioned herein.